Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program

BACKGROUND: Bone-only (BO) metastatic breast cancer (MBC) is considered a more favorable entity than other MBC presentations. However, only few retrospective series and data from selected randomized controlled trials have been reported so far. METHODS: Using the French national multicenter ESME (Epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertho, Marion, Fraisse, Julien, Patsouris, Anne, Cottu, Paul, Arnedos, Monica, Pérol, David, Jaffré, Anne, Goncalves, Anthony, Lebitasy, Marie-Paule, D’Hondt, Véronique, Dalenc, Florence, Ferrero, Jean-Marc, Levy, Christelle, Dabakuyo, Sandrine, Rouzier, Roman, Penault-Llorca, Frédérique, Uwer, Lionel, Eymard, Jean-Christophe, Breton, Mathias, Chevrot, Michaël, Thureau, Sébastien, Petit, Thierry, Simon, Gaëtane, Frénel, Jean-Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841864/
https://www.ncbi.nlm.nih.gov/pubmed/33613700
http://dx.doi.org/10.1177/1758835920987657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841864/
https://www.ncbi.nlm.nih.gov/pubmed/33613700
http://dx.doi.org/10.1177/1758835920987657

Ejemplares similares